0
0
10/19/22 at 6:17pm
Organization
The Washington Post
30 words
0
Comments
The panel rejected arguments that Makena should remain available for high-risk groups, including some Black women.
You are the first to view
https://www.washingtonpost.com/health/2022/10/19/makena-preterm-birth-fda-advisers-black-women/
Create an account
or login to join the discussion